Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis.
作者信息
Zhao Chenyang, Cui Zhao, Zhang Yimiao, Wang Fang, Wang Xin, Cheng Xuyang, Meng Liqiang, Liu Gang, Zhao Minghui
机构信息
Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University; Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing 100034, China.
Peking-Tsinghua Center for Life Sciences, Beijing 100871, China.
出版信息
Chin Med J (Engl). 2022 Apr 5;135(7):866-868. doi: 10.1097/CM9.0000000000001855.
Abstract
摘要
Zotero 插件